Literature DB >> 15037162

The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.

L Jackson Roberts1, Joshua P Fessel.   

Abstract

F2-isoprostanes are prostaglandin F2-like compounds that are formed nonenzymatically by free radical mediated peroxidation of arachidonic acid. Intermediate in the pathway of the formation of isoprostanes are labile prostaglandin H2-like bicyclic endoperoxides (H2-isoprostanes), which are reduced to F2-isoprostanes and also undergo rearrangement in vivo to form E-ring and D-ring isoprostanes, isothromboxanes, and highly reactive acyclic gamma-ketoaldehdyes (isoketals). Docosahexaenoic acid (C22:6omega3) is highly enriched in neurons in the brain and is highly susceptible to oxidation. Free radical mediated oxidation of docosahexaenoic acid results in the formation of isoprostane-like compounds (neuroprostanes). F4- and E4/D4-neuroprostanes as well as neuroketals have been shown to be produced in vivo. Finally, we recently discovered a new pathway of lipid peroxidation that forms compounds with a substituted tetrahydrofuran ring (isofurans). Oxygen concentrations differentially modulate the formation of isoprostanes and isofurans; at elevated oxygen concentrations, the formation of isofurans is favored whereas the formation of isoprostanes is disfavored.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037162     DOI: 10.1016/j.chemphyslip.2003.09.016

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  32 in total

Review 1.  Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

Authors:  Matthew Spite; Charles N Serhan
Journal:  Circ Res       Date:  2010-11-12       Impact factor: 17.367

2.  Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?

Authors:  Tomas B Corcoran; Emilie Mas; Anne E Barden; Thierry Durand; Jean-Marie Galano; L Jackson Roberts; Michael Phillips; Kwok M Ho; Trevor A Mori
Journal:  Antioxid Redox Signal       Date:  2011-07-22       Impact factor: 8.401

3.  Vitamin C distribution and retention in the mouse brain.

Authors:  Fiona E Harrison; Roslyn J Green; Sean M Dawes; James M May
Journal:  Brain Res       Date:  2010-06-04       Impact factor: 3.252

Review 4.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 5.  New approaches to neuroprotection in infant heart surgery.

Authors:  Erin L Albers; David P Bichell; Bethann McLaughlin
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

6.  Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery.

Authors:  Tomas B Corcoran; Anne E Barden; Emilie Mas; Sina Grape; Viktoria Koren; Michael Phillips; L Jackson Roberts; Trevor A Mori
Journal:  Free Radic Biol Med       Date:  2011-06-27       Impact factor: 7.376

Review 7.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

8.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

9.  Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets.

Authors:  Fadi T Khasawneh; Jin-Sheng Huang; Fozia Mir; Subhashini Srinivasan; Chinnaswamy Tiruppathi; Guy C Le Breton
Journal:  Biochem Pharmacol       Date:  2008-03-30       Impact factor: 5.858

10.  Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Authors:  Sherry L Spinelli; Katie L Lannan; Ann E Casey; Amanda Croasdell; Timothy M Curran; Kelly F Henrichs; Stephen J Pollock; Ginger A Milne; Majed A Refaai; Charles W Francis; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2013-11-05       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.